X0704 D LIVE 0001044378 BIOCEPT INC 5810 NANCY RIDGE DR SAN DIEGO CA CALIFORNIA 92121 858-320-8200 CALIFORNIA None None Corporation true Todd Johnson c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Edward Neff c/o SMAC Corporation 5807 Van Allen Way Carlsbad CA CALIFORNIA 92008 Director Edward Dennis c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Daniel Petree c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Claire Reiss c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Faye Wilson c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Bruce Gerhardt c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Ivor Royston c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Director Meg McGilley c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Farideh Bischoff c/o Biocept, Inc. 5810 Nancy Ridge Drive, Suite 150 San Diego CA CALIFORNIA 92121 Executive Officer Interim Chief Scientific Officer Biotechnology Decline to Disclose 06 false 2011-02-01 false true true true false Securities offered consist of promissory notes convertible into shares of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and the common stock underlying the convertible preferred stock. 0 6000000 1200000 4800000 Amount listed above under Total Offering Amount includes $1,000,000 receivable by the Issuer upon the exercise of warrants to purchase shares of the Issuers Convertible Preferred Stock. Such warrants have not been exercised. false 1 0 0 0 false BIOCEPT INC /s/ Meg McGilley Meg McGilley CFO 2011-02-14